Tag Archives: PLKI

Top 5 Warren Buffett Stocks To Own For 2018

Berkshire Hathaway Chairman and CEO Warren Buffett

Yesterday, Warren Buffett, the chairman and CEO of Berkshire Hathaway Inc. (NYSE: BRK.A; BRK.B), said he thinks the United States will “work fine” under President Donald Trump.

His reason: America’s got the “secret sauce” – the ability to survive.

“America works,” Buffett told CNBC on Thursday (Jan. 19). “I’ve said this before. It’ll work wonderfully under [former Democratic presidential candidate] Hillary Clinton, and I think it’ll work fine under Donald Trump.”

The billionaire also conceded that he doesn’t think the United States works perfectly, “but you just look at where we go, milestone after milestone. Never bet against America.”

Buffett likewise took the CNBC interview yesterday as an opportunity to reiterate his call to invest now for the long haul…

Top 5 Warren Buffett Stocks To Own For 2018: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Snap-on (SNA)

    Snap-on, which is more than 100 years old, provides hand and power tools for individuals and professionals, including auto-shop tools and auto diagnostic equipment.

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews Nick Pinchuk, CEO of Snap-on (SNA) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By John Divine]

    Snap-on Incorporated (SNA) is my choice for the Best Stocks for 2016 competition. At a market cap of $10 billion, I doubt it will double over the next year, as some of the smaller companies in this competition might be able to.

    That said, Snap-on, which manufactures and markets hand tools and diagnostic equipment, is a rock-solid company with an attractive valuation and impressive growth. It goes for 22 times earnings, pays a consistent and modest dividend, and has been around since 1920.

    As cars get more tech-heavy and complicated, newer tools and better diagnostics will be needed — and that’s SNA’s bread ‘n’ butter. 

Top 5 Warren Buffett Stocks To Own For 2018: Popeyes Louisiana Kitchen, Inc.(PLKI)

Advisors’ Opinion:

  • [By Daniel Miller]

    While chicken and burgers might not sound like a match made in heaven for dinner, it could be tasty for investors inRestaurant Brands International (NYSE:QSR). The parent company of Burger King agreed to purchase Popeyes Louisiana Kitchen Inc. (NASDAQ:PLKI).

  • [By Monica Gerson]

    Popeyes Louisiana Kitchen Inc (NASDAQ: PLKI) is estimated to post its quarterly earnings at $0.64 per share on revenue of $85.31 million.

    SpartanNash Co (NASDAQ: SPTN) is expected to post its quarterly earnings at $0.49 per share on revenue of $2.28 billion.

  • [By Ashley Moore]

    Popeyes Louisiana Kitchen Inc. (Nasdaq: PLKI) stock is up 19% today (Tuesday) after Burger King’s parent company, Restaurant Brands International Inc. (NYSE: QSR), announced it will buy the fast-food chicken company.

Top 5 Warren Buffett Stocks To Own For 2018: Cummins Inc.(CMI)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    There are lots of stories like that out there these days. People were perplexed about the Illinois Tool Works (ITW) and Cummins Engine (CMI) and Caterpillar (CAT) quarters, but they turned out to be classic buying opportunities after years of being sell opportunities if the stocks had run. I can’t explain to you how amazing that is. Here are three stocks that have spent months and months in purgatory when they have missed or guided down or slashed forecasts. Now they are up gigantically.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Cummins Inc. (NYSE: CMI) which traded down about 5% at $159.44. The stocks 52-week range is $134.06 to $181.79. Volume was over 3.5 million versus the daily average of 1.2 million shares.

  • [By Reuben Gregg Brewer]

    Making mining equipment has been a horrible business over the last few years. The industry has been hard-hit by the spending cutbacks at mine sites around the world. For example, BHP Billiton Limited trimmed its capital exploration expenditures by roughly 70% between fiscal 2013 and 2016. No wonder Caterpillar Inc. (NYSE:CAT), Komatsu Ltd. (NASDAQOTH:KMTUY), and Cummins Inc. (NYSE:CMI) have been hurting. Only that looks like it’s starting to change, which means this trio could be at the top of a list of mining equipment companies to buy in 2017.

  • [By Reuben Gregg Brewer]

    Ever walk past a construction site? It’s hard not to be enthralled by all the heavy construction machinery moving things around. With the world’s developing economies still building at a relatively fast pace and developing economies, like the United States, in desperate need of upgrading their aging infrastructure, the companies behind that construction machinery could be just as exciting as a construction site in the years ahead. Which is why Caterpillar Inc. (NYSE:CAT), Cummins Inc. (NYSE:CMI), and Terex Corporation (NYSE:TEX) are three of the top construction machinery stocks to look at right now.

Top 5 Warren Buffett Stocks To Own For 2018: Tele Celular Sul Participacoes S.A.(TSU)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares fell 0.45 percent. Meanwhile, top losers in the sector included Shenandoah Telecommunications Company (NASDAQ: SHEN), down 3 percent, and TIM Participacoes SA (ADR) (NYSE: TSU) down 2 percent.

Top 5 Warren Buffett Stocks To Own For 2018: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Dimitra DeFotis]

    Shares of Eli Lilly (LLY) are down nearly 13% this morning after a late-stage Alzheimer’s drug trial failed to produce expected results.

    Biogen(BIIB), down nearly 6% today, also is working on an Alzheimer’s treatment; Merck (MRK) shareswere down 1% in recent trading.

    Lilly was testing the drug as a treatment for mild dementia due to Alzheimer’s disease.Credit Suisse analysts were hopeful the drug trial would show “a statistically significant impact on cognition.”MarketWatch reports:

    “Eli Lilly said it would not pursue approval for the drug to treat mild dementia due to Alzheimers disease and that it will ‘evaluate the impact of these results on the development plans for solanezumab and our other Alzheimers pipeline assets’ … More specifics about the solanezumab drug, expected the night of Dec. 9 during a meeting of the Clinical Trials on Alzheimers Disease (CTAD), could have repercussions for whats called the beta amyloid hypothesis in Alzheimers disease treatments, which target protein fragments that some believe are responsible for the disease …”

    On Nov. 15, J.P. Morgan analysts Chris Schott, Aditi Singhania, Dana Flanders and Christopher Neyor noted that trial success had a low probability. But they kept their$95 price target on the stock, noting the drug pipeline offers other opportunities. Their target implies upside of more than 40% from a recent price near $66. They wrote:

    “… On solanezumab … While the FDA recommends both cognitive and function endpoints for Alzheimers drug approvals, we expect the agency to review solanezumab on the totality of evidence, and we would not be surprised to see a cognitive benefit coupled with a trend in secondary functional endpoints be sufficient for approval … regardless of the solanezumab outcome, we see a diverse range of new product opportunities supporting LLY

  • [By Johanna Bennett]

    Eli Lilly & Co. (LLY) and Biogen (BIIB) are far from the only two drug makers racing to deliver a new treatment for Alzheimers disease. But they are pretty much leading the pack.

    The market for an effective therapy that actually slows the progression of the disease would likely generate billions of dollars in annual sales. It is quite literally the drug industrys version of the holy grail.

    And according to Barclays analysts Geoff Meacham and Paul Choi, the next few weeks could prove to be one of the most fertile periods in Alzheimers disease research since 2008.

    We think the most likely outcome for Lilly’s Phase 3 EXPEDITION 3 (E3) solanezumab trial is the primary cognition (ADAS-Cog14) endpoint is met (just achieving statistical significance with a p-value <0.05) and mixed results on the secondary endpoints including function (ADL), which we believe should be good enough to support a regulatory submission. While aducanumab has a marginally different mechanism of action, we nevertheless expect BIIB shares to trade in sympathy to Lilly.

    Implications for Biogen and Merck: The E3 results are likely to result in volatility for Biogen (up 20-30%, down 10-15%) as Alzheimer’s drives both long-term growth and M&A value even though aducanumab works differently from solanezumab.

    Aducanumab dose titration data is expected at the CTAD meeting (San Diego, Dec. 9). Merck’s Phase 2/3 EPOCH verubecestat (BACE) trial is scheduled to finish in June 2017 but unlike E3, PET scans/CSF tests for A were not an inclusion criteria. We think Merck shares could move 3% to 5% in either direction in sympathy to E3.

    At $76.58, Lillys share price has fallen more than 9% over the past year, while Biogen has climbed more than 9% over the same span.

  • [By Maxx Chatsko]

    Both Evenity and Tymlos are anabolic treatments, which means they encourage bone growth, rather than merely preventing bones from becoming more brittle, as prior generation osteoporosis drugs have done. While Eli Lilly (NYSE:LLY) was the first to market a drug in this class when Forteo gained marketing approval in 2002, it has faced no competitors despite achieving $1.5 billion in global sales last year, including $770 million in the United States. All of its patents expire by August 2019.

  • [By Keith Speights]

    With this rapidly growing market, there are plenty of opportunities for investors. Zoetis (NYSE:ZTS), Merck (NYSE:MRK), and Eli Lilly (NYSE:LLY) stand out as the top animal-health companies to buy in 2017. Here’s why.

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

investment adviser

Lululemon Athletica (LULU) is scheduled to release its financial results on March 29 after the market close. And while half of the 36 analysts who Lululemon rate it a Buy or Outperform, that still means another half, well, don’t.

Kevork Djansezian/Getty Images

Count Macquarie’s Laurent Vasilescu and team among the latter. In a note today, they offered 10 reasons to be cautious about Lululemon, which they rate Underperform. Here are my excerpts:

Same-store Sales: “We are concerned that store comps are in the low single digits, especially since the store fleet is very young,” Vasilescu warns. Margin Disclosure: “The level of disclosure around the gross margin continues to decrease,” Vasilescu claims. Margin Sapping Businesses: “Mens and ivivva are both growth drivers yet they are
margin dilutive,” Vasilescu explains. Too many stores in the U.S.: “Prior management outlined many times the TAM of 300-350 stores in North America,”Vasilescu writes. “Lulu is reaching saturation.” U.S. Store Profitability: It’s much lower than in Canada, claims Vasilescu. Marketing: Not enough of it, especially compared to Nike (NKE), Adidas (ADDYY), and Under Armour (UAA), Vasilescu says. Not a tech company: On its third-quarter conference call, Lululemon said it was a quasi-tech company. It’s not, says Vasilescu. Competition: Denim. Beyonce. Amazon.com (AMZN). Ouch. High costs: “When comps turn negative we think this will pressure earnings, as we estimate high fixed SG&A costs,” write Vasilescu. Inventories: “Days in inventory remain elevated at 112 vs historical 3Q rate of 90,” warns Vasilescu.

Shares of Lululemon Athletica have gained 0.6% to $64.06 at 2:32 p.m. today, while Nike has fallen 0.9% to $55.86, Adidas has dipped 0.1% to $96.27, Under Armour has risen 0.9% to $19.83, and Amazon.com has ticked up 0.1% to $846.38.

investment adviser: Popeyes Louisiana Kitchen, Inc.(PLKI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Popeyes Louisiana Kitchen Inc (NASDAQ: PLKI) is estimated to post its quarterly earnings at $0.64 per share on revenue of $85.31 million.

    SpartanNash Co (NASDAQ: SPTN) is expected to post its quarterly earnings at $0.49 per share on revenue of $2.28 billion.

  • [By Ashley Moore]

    Popeyes Louisiana Kitchen Inc. (Nasdaq: PLKI) stock is up 19% today (Tuesday) after Burger King’s parent company, Restaurant Brands International Inc. (NYSE: QSR), announced it will buy the fast-food chicken company.

  • [By Daniel Miller]

    While chicken and burgers might not sound like a match made in heaven for dinner, it could be tasty for investors inRestaurant Brands International (NYSE:QSR). The parent company of Burger King agreed to purchase Popeyes Louisiana Kitchen Inc. (NASDAQ:PLKI).

investment adviser: Advance Auto Parts Inc(AAP)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    So here’s a disruptive move. Consider buying auto parts retailer Advance Auto Parts (AAP) , the weakest of the big three in the sector, which has 5,000-plus locations in the U.S. The other two players are O’Reilly Automotive, Inc. (ORLY) , the fastest-growing of the three, and AutoZone, Inc. (AZO) .

  • [By Spencer Israel]

     

    Riot Blockchain Inc (NASDAQ: RIOT) – The Jan. 2015 high of $15.72 is the only resistance it has.
    General Electric Company (NYSE: GE) -The low of the move is a double bottom at $17.46 and  $17.50. That’s support.
    Overstock.com Inc (NASDAQ: OSTK) – The February 2005 high was $58.24, which is the only relevant resistance up here. On weakness, keep an eye on the all-time closing high of $56.65 made on Monday.
    Advance Auto Parts, Inc. (NYSE: AAP) – Is trying to fill the gap from earnings between $82.82 and $94.75.
    Tesla Motors Inc (NASDAQ: TSLA) – It needs to clear Friday’s close of $315.05 and Monday’s high of $315.50 to find support.
    Urban Outfitters, Inc. (NASDAQ: URBN) – There was a double close at $27.90 from Friday and $28.27 from Monday, so that’s resistance.
    DSW Inc. (NYSE: DSW) -The premarket low was $18.40. There are also four daily lows at the $18.40 area from early November, and the low of the move is $17.89.
    Signet Jewelers Ltd. (NYSE: SIG) – the premarket low was $61.50, which was the low of the move. There’s daily lows at the $61 area from mid-August, and another pair of lows at $60. Below that, there’s a gap area down to $52.95.
    Lowe’s Companies, Inc. (NYSE: LOW)- The Friday low was $79.17, and a pair of lows from Wednesday and Thursday at $78.27 and $78.23.
    Campbell Soup Company (NYSE: CPB) – The buy zone is between $45-$46. The low of the move was $44.99, flanked by the $45.14 low the following day.
    Dollar Tree, Inc. (NASDAQ: DLTR) – $99.93 and a big psychological number at $100.
    Burlington Stores Inc (NYSE: BURL) – The Monday low was $104.55. The all-time high and all-time closing high are $106.55 and $106.89, respectively. 
    Exxon Mobil Corporation (NYSE: XOM) – Big triple bottom at $80.

    Watch the full show below!

  • [By ]

    3. Advance Auto Parts (NYSE: AAP)
    A leader in the consumer auto parts space, Advance boasts over 5,200 stores, 100 Worldpac branches, and serves more than 1,300 independently owned CARQUEST branded shops.

  • [By Ben Levisohn]

    Advance Auto Parts (AAP) surged to the top of the S&P 500 today after releasing better-than-expected third-quarter earnings.

    Getty Images

    Shares of Advance Auto Parts gained 15% to $164.33, while the S&P 500 rose 0.8% to 2,180.39.

    Credit Suisse analyst Seth Sigman and team explain why shares of Advance Auto Parts are soaring:

    Advance Auto Parts’ Q3 and strategic update was one of the better scenarios for this stock with better than expected comps, positive commentary on Q4, a roughly in line 2017 outlook, and a new sense of direction on how this new management team will narrow the margin gap with peers. Management guided to a 500 bps long-term margin improvement, which wasnt a surprise to investors, and other specifics were still limited. However, timed with Q3/4′s improvement, this should help instill some early confidence in this team. We are adjusting our 2016 and 2017 EPS modestly, to $7.30 (from $7.23) and to $7.65 (from $7.60) respectively.

    Advance Auto Parts market capitalization rose to $12.1 billion today from $10.7 billion yesterday.

investment adviser: Alphabet Inc.(GOOGL)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Alphabet Inc.’s (NASDAQ: GOOGL) Google was one of the first companies to field early experiments in self-driving cars. By late last year, Google’s vehicles had covered over 2 million miles on public roads. Google has spun out its driverless car operation into a company called Waymo. Its management commented:

  • [By Elizabeth Balboa]

    The marketing and sales software platform is also facing competition from the likes of Alphabet Inc (NASDAQ: GOOGL) and Facebook Inc (NASDAQ: FB).

    “At best, HubSpot is worth SaaS [software as a service] comps,” Left wrote. “We give it the benefit of the doubt and give it take-out valuations… Hubspot is more in line with a content marketing company whose takeout valuations are 2x revenue.”

  • [By Daniel Sparks]

    Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) has put its first-quarter earnings release date on the calendar. The internet search giant will report results for its most recently ended quarter on Thursday, April 27. After missing estimates for earnings per share in its most recent quarter, investors will be watching the company’s profitability closely.

  • [By WWW.THESTREET.COM]

    Are you sensing a little resistance? Cramer and the AAP team look at Apple (AAPL) , Facebook (FB) , Alphabet (GOOGL) , and Schlumberger (SLB) in their weekly roundup. Be ready for the week ahead and find out what they’re telling their investment club members with a free trial subscription to Action Alerts PLUS.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Amazon.com, Inc. (NASDAQ: AMZN): Free Stock Analysis Report
     
    Netflix, Inc. (NASDAQ: NFLX): Free Stock Analysis Report
     
    Facebook, Inc. (NASDAQ: FB): Free Stock Analysis Report
     
    Alphabet Inc. (NASDAQ: GOOGL): Free Stock Analysis Report
     
    Apple Inc. (NASDAQ: AAPL): Free Stock Analysis Report
     
    SPDR-TECH SELS (ETF:XLK): ETF Research Reports
     
    NASDAQ-100 SHRS (NASDAQ: QQQ): ETF Research Reports
     
    SPDR-SP 500 TR (ETF:SPY): ETF Research Reports
     
    PWRSH-DYN SEMI (ETF:PSI): ETF Research Reports
     
    ISHARS-NA TEC-S (ETF:IGV): ETF Research Reports
     
    FIRST N-100 TEC (NASDAQ: QTEC): ETF Research Reports
     
    FT-TECH ALPHA (ETF:FXL): ETF Research Reports
     
    FT-NDQ SEMICON (FTXL): ETF Research Reports
     
    NVIDIA Corporation (NASDAQ: NVDA): Free Stock Analysis Report
     
    Macy's Inc (NYSE: M): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research
     
    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

investment adviser: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

    Read more of Cramer’s comments about the stocks in the Lightning Round.

  • [By WWW.MONEYSHOW.COM]

    Prudential Financial (PRU) is also a major provider of asset management and retirement services. It focuses is on fixed income, a major liability during the past eight years of ultra-low interest rates.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) has long had the Rock of Gibraltar as its corporate symbol, representing its solid financial position. With more cash and equivalents than debt on its balance sheet, and a total cash hoard of over $49 billion, Prudential still looks set up to handle some downright awful insurable losses. That’s its “Rock of Gibraltar” strength showing through.

investment adviser: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

  • [By James E. Brumley]

    Don’t be surprised if Lexaria Bioscience Corp (OTCMKTS:LXRP) shares seem a little peppier and even more bullish than usual for the next three months, give or take… and that’s saying something considering LXRP is 158% since early October, and up 47% since mid-December. Why’s that? The organization has hired a publicity firm to help tell its story to an even bigger audience, and that attention could attract a whole new batch of buyers for the stock.

    Granted, the Lexaria Bioscience story is a compelling one to begin with.

    If 2016 (and 2017 so far) were to be pegged with any major investment “themes,” cannabis would have to be it. Marijuana/hemp — cannabinoids, ultimately — was on the ballot for one reason or another in nine states this past November, and those pro-cannabis measures passed in eight of those votes. As such, cannabis is now legal for at least one reason in 26 states of the United States, and the movement is still gathering momentum.

    And well it should. The recreational aspect of marijuana and cannabinoids aside, hemp (a form of cannabis plant that isn’t the kind of marijuana that provides a “high”) delivers a multitude of health benefits. Specifically, users of hemp oil find the plant-based oil improves immunity, improves cardiovascular health, moderates blood sugar, treats skin conditions, treats arthritis, inhibits osteoporosis, fights some mental disorders, and in some cases has been found to be an anti-cancer agent. Lexaria Bioscience is simply enhancing these benefits of hemp oil by enhancing the amount of hemp oil a human body can absorb when ingested.

    Simply put, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. The key to the science is the fact that Lexaria Bioscience is able to combine cannabinoids with lipids — or fatty acids — at the molecular level. It matters, because the human endocannabinoid system is it

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Jim Robertson]

    Small cap Lexaria Bioscience Corp (OTCQB: LXRP)is a food sciences company focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies.This technology enables higher bioavailability rates for CBD, THC, NSAIDs, Nicotine and other molecules than is possible without lipophilic enhancement technology allowing for lower overall dosing requirements and/or higher effectiveness in active molecule delivery.The Companyhopes to reduce other common, but less healthy ingestion methods such as smoking as it embraces the benefits of public health.

  • [By Jim Robertson]

    In October, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP) was issuedU.S. Patent No. 9,474,725 Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof and now the company is seeking to expand this patent internationally. This patent protects Lexaria Bioscience Corps intellectual property related to infusion of cannabinoid compounds in edible products and includes a set of claims that describe the Companys method of combining a fatty acid compound with any non-psychoactive cannabinoid for improved bioavailability and taste performance in both food and beverage formats.

  • [By James E. Brumley]

    Are hemp and marijuana one and the same? It depends who you ask. The federal government accurately recognizes that hemp and marijuana are variants of the same species, Cannabis sativa. Yet, poodles and German shepherds are also from the same species, and the two couldn’t be any more different types of dogs. The same goes for marijuana and hemp. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), which is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.

    The good news is, governments – federal and state – are finally starting to wise up to the distinct differences between marijuana and hemp, and that bodes well for a young startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

    Lexaria Bioscience Corp. is “a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.”

    In other words, it solves a problem within the budding (no pun intended) world of cannabis and medical — or even recreational — marijuana. It increases the amount of absorption of a substance ingested.

    The science has applications in everything from vitamins to supplements to painkillers, but LXRP is starting with the hemp oil for good reason.

    Hemp seeds (which are technically a nut and are als

Top 10 Casino Stocks To Buy For 2018

Related MGM Vegas Strip Revenue Slumps In July Callaway's Stake In TopGolf Nearly Doubles In A Year, Now Worth $400 Million This Casino Giant Breaks Out As Typhoon Can't Stop Macau Gaming (Investor’s Business Daily)
Related SEAS Resurrected: Zombie Headlines And How Old News Can Move Stocks Earnings Scheduled For August 8, 2017

Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity.

Here's a recap of the options alerts from Tuesday, September 5, 2017. All time stamps are in Eastern Time.

3:46:03 pm: MGM MGM Sep 15 $33.5 Puts Sweep (11) at the Bid: 616 @ $0.92 vs 46 OI; Ref=$33.15

3:01:11 pm: SEAS SeaWorld Oct 20 $12 Puts Sweep (3) at the Ask: 846 @ $0.551 vs 173 OI; Ref=$12.315

2:53:21 pm: INCY Incyte Jun 15 $125 Puts Sweep (2) at the Ask: 700 @ $15.2 vs 0 OI; Ref=$135.09

Top 10 Casino Stocks To Buy For 2018: James River Group Holdings, Ltd.(JRVR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PhiloSmith Capital Corp’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PhiloSmith+Capital+Corp

    These are the top 5 holdings of PhiloSmith Capital CorpPrimerica Inc (PRI) – 122,700 shares, 7.85% of the total portfolio. Chubb Ltd (CB) – 61,750 shares, 7.59% of the total portfolio. Reinsurance Group of America Inc (RGA) – 65,550 shares, 7.11% of the total portfolio. Brown & Brown Inc (BRO) – 193,225 shares, 7.03% of the total portfolio. Arthur J. Gallagher & Co (AJG) – 143,725 shares, 6.95% of the to

Top 10 Casino Stocks To Buy For 2018: Mammoth Energy Services, Inc. (TUSK)

Advisors’ Opinion:

  • [By Jack Delaney]

    Mammoth Energy Services (Nasdaq: TUSK) provides drilling and related services for North American gas and oil explorers.

    Even though Mammoth was just founded in 2014, it had $243 million in revenue between June 30, 2015, and June 30, 2016.

Top 10 Casino Stocks To Buy For 2018: Tele Celular Sul Participacoes S.A.(TSU)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares fell 0.45 percent. Meanwhile, top losers in the sector included Shenandoah Telecommunications Company (NASDAQ: SHEN), down 3 percent, and TIM Participacoes SA (ADR) (NYSE: TSU) down 2 percent.

Top 10 Casino Stocks To Buy For 2018: Apartment Investment and Management Company(AIV)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Apartment Investment & Management (AIV) tumbled today, as the weakness in real-estate investment trusts following Donald Trump’s surprise election continued today. It was the second-biggest loser in the S&P 500 today.

    Getty Images

    Shares of Apartment Investment & Management dropped 4.1% to $41.03 today, while the Real Estate SPDR Dow Jones REIT ETF (RWR) fell 1.1% to $90.03. The S&P 500 rose rose 0.8% to 2,180.39.

    In a note released yesterday, Raymond James analyst Buck Horne and team cut their price target on Apartment Investment & Management to $50 from $50, even as they maintained their Strong Buy rating. They explain why:

    Prefacing our comment qualifying the significant economic uncertainties that have arisen post Tuesdays election, we are maintaining our Strong Buy rating onApartment Investment & Management shares while slightly adjusting our target price (to $50 from $52) and net-asset-value estimate (down $1 to $48.51/share). These adjustments are solely to reflect slightly more conservatism in our cap rate assumptions following the post-election interest rate shifts. We continue to find Apartment Investment & Managements risk/reward profile compelling in this environment as its diversified class B-priced portfolio should prove more resilient to supply pressures and benefit from the growing shortage of affordable workforce housing. In an inflationary environment with potentially declining housing affordability, we are particularly attracted to Aimcos price points, demographics, and balance sheet full of long-dated, non-recourse, fixed rate leverage.

    Apartment Investment & Management reported net income of $67 million on sales of $978 million in 2015.

  • [By Ben Levisohn]

    Scripps Networks Interactive (SNI) sunk to the bottom of the S&P 500–narrowly beating out Apartment Investment and Management (AIV)–as the parent company of the Food Network and other channels gave back a chunk of its post-elections gains.

Top 10 Casino Stocks To Buy For 2018: Omeros Corporation(OMER)

Advisors’ Opinion:

  • [By Paul Ausick]

    Stocks on the move: Boise Inc. (NYSE: BZ) is up 26% at $12.55 following the companys acquisition by Packaging Corporation of America Inc. (NYSE: PKG) for $12.55 a share ($1.28 billion). Omeros Corp. (NASDAQ: OMER) is up 68.2% at $8.56 following an analyst upgrade. Northern Dynasty Minerals Ltd. (NYSEArca: NAK) is down 33.3% at $1.48 following an announcement from Anglo American plc that it was withdrawing from a massive copper mining project in Alaska.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.09 percent. Meanwhile, top losers in the sector included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), down 6 percent, and Omeros Corporation (NASDAQ: OMER), down 5 percent.

  • [By Monica Gerson]

    Omeros (NASDAQ: OMER) shares fell 2.80% to $8.32 in the pre-market trading. Omeros shares have dropped 9.80% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.

  • [By Lisa Levin]

    Shares of Omeros Corporation (NASDAQ: OMER) got a boost, shooting up 31 percent to $18.52 after the company reported strong results for its third quarter.

  • [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
    Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
    Gainers
    Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
    SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
    The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
    Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
    AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
    Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
    First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
    Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to

Top 10 Casino Stocks To Buy For 2018: Popeyes Louisiana Kitchen, Inc.(PLKI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Popeyes Louisiana Kitchen Inc (NASDAQ: PLKI) is estimated to post its quarterly earnings at $0.64 per share on revenue of $85.31 million.

    SpartanNash Co (NASDAQ: SPTN) is expected to post its quarterly earnings at $0.49 per share on revenue of $2.28 billion.

  • [By Ashley Moore]

    Popeyes Louisiana Kitchen Inc. (Nasdaq: PLKI) stock is up 19% today (Tuesday) after Burger King’s parent company, Restaurant Brands International Inc. (NYSE: QSR), announced it will buy the fast-food chicken company.

  • [By Daniel Miller]

    While chicken and burgers might not sound like a match made in heaven for dinner, it could be tasty for investors inRestaurant Brands International (NYSE:QSR). The parent company of Burger King agreed to purchase Popeyes Louisiana Kitchen Inc. (NASDAQ:PLKI).

Top 10 Casino Stocks To Buy For 2018: American Eagle Outfitters, Inc.(AEO)

Advisors’ Opinion:

  • [By Paul Ausick]

    American Eagle Outfitters Inc. (NYSE: AEO) dropped nearly 16% Wednesday to post a new 52-week low of $10.91 after closing at $12.96 on Tuesday. The stock’s 52-week high is $19.55. Volume of nearly 23 million was about 5 times the daily average of around 4.7 million shares traded. The specialty retailer’s results didn’t live up to expectations this morning.

  • [By Leo Sun]

    Over the past few decades, American Eagle Outfitters (NYSE:AEO), Urban Outfitters (NASDAQ:URBN), and Gap (NYSE:GPS) all turned modest initial investments of $8,000 into small fortunes. Let’s see how these companies flourished, and whether or not they can still keep growing in today’s challenging retail environment.

  • [By Lisa Levin]

    Shares of American Eagle Outfitters (NYSE: AEO) were down 12 percent to $11.35 after the company posted downbeat quarterly earnings and issued a weak earnings forecast for the current quarter.

  • [By Nicholas Rossolillo]

    However, the ongoing closures could help remaining shopping mall businesses like The Gap (NYSE:GPS)and American Eagle Outfitters (NYSE:AEO). Neither company has been immune to the changing times and both have closed down stores of their own. However, some of these clothiers — American Eagle, in particular — have managed to hang on to old clientele and expand into new markets.

Top 10 Casino Stocks To Buy For 2018: Targa Resources, Inc.(TRGP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares fell by 0.37 percent. Meanwhile, top losers in the sector included Targa Resources Corp (NYSE: TRGP), down 3 percent, and FirstEnergy Corp. (NYSE: FE), down 2 percent.

Top 10 Casino Stocks To Buy For 2018: Schnitzer Steel Industries, Inc.(SCHN)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    I’m adding Schnitzer Steel Industries (SCHN) to the Buy Low Opportunities Portfolio. Schnitzer Steel is both a recycler of scrap metals, and a manufacturer of steel products that are used in nonresidential construction.

  • [By WWW.THESTREET.COM]

    Cramer said he’s starting the week watching for the latest read on durable goods orders, which will likely be bad. But he’s also on the lookout for Schnitzer Steel (SCHN) , which popped 6.9% today on a promised executive action against illegal dumping. Cramer expects more positive action in the steels to come.

Top 10 Casino Stocks To Buy For 2018: Select Medical Holdings Corporation(SEM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Overvalued companies include MWI Veterinary (MWIV) andStericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but callsAratana (PETX) a “hidden gem.”

Top Safest Stocks To Buy For 2018

U.S. stocks fell on Wednesday, slumping in a broad decline as the markets multiweek rallywhich has taken indexes to repeated records and the Dow within mere points of the 20,000 milestonestalled.

All 11 of the S&P 500s primary sectors ended lower on the day, while the benchmark index itself suffered its biggest one-day point and percentage drop since October. Financials and materials, two of the best-performing industries of late, were among the hardest hit, with both down about 1%.

Top Safest Stocks To Buy For 2018: SemiLEDS Corporation(LEDS)

Advisors’ Opinion:

  • [By Ross Cameron – Warrior Trading]

    I look at stocks like Sunshine Heart Inc (NASDAQ: CHFS), which has a beta of 2.38 (remember, a beta greater than 1 means more volatility), or SemiLEDs Corporation (NASDAQ: LEDS), with a beta of 2.26. Both of these have been recent winners for me. If this means I’m trading penny stocks, then that’s fine. My key is to stick with my system, which is why I’ve been successful — and had the best day of my career).

  • [By Lisa Levin]

    SemiLEDs Corporation (NASDAQ: LEDS) was down, falling around 17 percent to $6.75 following Q2 earnings report. SemiLEDS reported a Q3 loss of $1.06 per share on revenue of $2.4 million.

  • [By Monica Gerson]

    SemiLEDs Corporation (NASDAQ: LEDS) is estimated to post its quarterly earnings.

    Staffing 360 Solutions Inc (NASDAQ: STAF) is expected to post a quarterly loss at $0.28 per share.

Top Safest Stocks To Buy For 2018: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

    American Axle & Manufact. Holdings, Inc. (NYSE: AXL) is expected to report its quarterly earnings at $0.71 per share on revenue of $998.76 million.

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion. CST Brands shares declined 1.20 percent to close at $36.21 on Thursday.

Top Safest Stocks To Buy For 2018: Popeyes Louisiana Kitchen, Inc.(PLKI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Popeyes Louisiana Kitchen Inc (NASDAQ: PLKI) is estimated to post its quarterly earnings at $0.64 per share on revenue of $85.31 million.

    SpartanNash Co (NASDAQ: SPTN) is expected to post its quarterly earnings at $0.49 per share on revenue of $2.28 billion.

  • [By Ashley Moore]

    Popeyes Louisiana Kitchen Inc. (Nasdaq: PLKI) stock is up 19% today (Tuesday) after Burger King’s parent company, Restaurant Brands International Inc. (NYSE: QSR), announced it will buy the fast-food chicken company.

  • [By Daniel Miller]

    While chicken and burgers might not sound like a match made in heaven for dinner, it could be tasty for investors inRestaurant Brands International (NYSE:QSR). The parent company of Burger King agreed to purchase Popeyes Louisiana Kitchen Inc. (NASDAQ:PLKI).

Top Safest Stocks To Buy For 2018: Altura Mining Limited (ALTAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The question now is more about speed of EV implementation. On the supply side, it has been great to see LAC, Pilbara Minerals (OTCPK:PILBF) and Altura Mining (OTCPK:ALTAF) get funding, but the continued issues with Albemarle’s (NYSE:ALB) LaNegra II expansion and Orocobre (OTCPK:OROCF) ramping up to Phase 1 capacity of 17,500 tonnes/year of lithium carbonate are further evidence that lithium projects take time and have considerable execution risk.

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Top Safest Stocks To Buy For 2018: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Todd Campbell]

    After updating investors on its wide-ranging gene therapy research program at a key industry conference early in the month,shares ofbluebird bio(NASDAQ:BLUE) surged 20.7% higher in January,according toS&P Global Market Intelligence.